| Application no. and date | 16722388.2 (espacenet) (Federated) (European Patent Register), 20160509 | | Patent/reg. no. and date | DK/EP 3294283, 20230308 | | Publication date | 20180321 | | Priority no. and date | US 201562159703 P, 20150511 | | EP pub. no. and date |
EP 3294283 20180321 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 168166/BT/GP | | Inventor | RIZKALA, Adel Redmond, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
SHI, Victor Chengwei, c/o Novartis Pharma AG
Postfach
4002 Basel, CH,
CHEN, Fabian, c/o Novartis Pharma AG
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/225 (2006.01) , A61K 31/41 (2006.01) , A61P 9/04 (2006.01) | | Title | SACUBITRIL-VALSARTAN-DOSERINGSREGIME TIL BEHANDLING AF HJERTEINSUFFICIENS | | Int. application no. | IB2016052633 | | Int. publication no. | WO2016181284 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
